These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33743550)

  • 1. Responsible Inclusion of Pregnant Individuals in Eradicating HCV.
    Jhaveri R; Yee LM; Antala S; Murphy M; Grobman WA; Shah SK
    Hepatology; 2021 Sep; 74(3):1645-1651. PubMed ID: 33743550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling the potential effectiveness of hepatitis C screening and treatment strategies during pregnancy in Egypt and Ukraine.
    Hachicha-Maalej N; Collins IJ; Ades AE; Scott K; Judd A; Mostafa A; Chappell E; Hamdy-El-Sayed M; Gibb D; Pett S; Mariné-Barjoan E; Volokha A; Yazdanpanah Y; Deuffic-Burban S
    J Hepatol; 2023 May; 78(5):937-946. PubMed ID: 36669704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct-Acting Antivirals to Prevent Vertical Transmission of Viral Hepatitis C: When Is the Optimal Time to Treat?
    Cervino L; Hynicka LM
    Ann Pharmacother; 2018 Nov; 52(11):1152-1157. PubMed ID: 29681166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of ledipasvir and sofosbuvir, with or without ribavirin, for 12 weeks in patients with HCV genotype 3 or 6 infection.
    Gane EJ; Hyland RH; An D; Svarovskaia E; Pang PS; Brainard D; Stedman CA
    Gastroenterology; 2015 Nov; 149(6):1454-1461.e1. PubMed ID: 26261007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curing the historically incurable: treatment success with ledipasvir/sofosbuvir for chronic hepatitis C virus in a heavily treatment-experienced individual.
    Johnson SW; Davis MM; Stever LM; Priest DH
    J Clin Pharm Ther; 2016 Dec; 41(6):727-729. PubMed ID: 27670742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generic sofosbuvir-based direct-acting antivirals in hepatitis C virus-infected patients with chronic kidney disease.
    Manoj Kumar ; Nayak SL; Gupta E; Kataria A; Sarin SK
    Liver Int; 2018 Dec; 38(12):2137-2148. PubMed ID: 29676846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meeting the WHO hepatitis C virus elimination goal: Review of treatment in paediatrics.
    Kim NG; Kullar R; Khalil H; Saab S
    J Viral Hepat; 2020 Aug; 27(8):762-769. PubMed ID: 32386099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C Virus in Pregnancy: An Opportunity to Test and Treat.
    Fogel RS; Chappell CA
    Obstet Gynecol Clin North Am; 2023 Jun; 50(2):363-373. PubMed ID: 37149316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral Therapy in Patients with Hepatitis C Virus-Induced Cirrhosis.
    Bailly F; Pradat P; Virlogeux V; Zoulim F
    Dig Dis; 2015; 33(4):613-23. PubMed ID: 26159282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Hepatitis C during Pregnancy-Weighing the Risks and Benefits in Contrast to HIV.
    Barritt AS; Jhaveri R
    Curr HIV/AIDS Rep; 2018 Apr; 15(2):155-161. PubMed ID: 29470782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: direct-acting antivirals for the treatment of HCV during pregnancy and lactation - implications for maternal dosing, foetal exposure, and safety for mother and child.
    Freriksen JJM; van Seyen M; Judd A; Gibb DM; Collins IJ; Greupink R; Russel FGM; Drenth JPH; Colbers A; Burger DM
    Aliment Pharmacol Ther; 2019 Oct; 50(7):738-750. PubMed ID: 31448450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic hepatitis C virus infection in Rwanda with ledipasvir-sofosbuvir (SHARED): a single-arm trial.
    Gupta N; Mbituyumuremyi A; Kabahizi J; Ntaganda F; Muvunyi CM; Shumbusho F; Musabeyezu E; Mukabatsinda C; Ntirenganya C; Van Nuil JI; Kateera F; Camus G; Damascene MJ; Nsanzimana S; Mukherjee J; Grant PM
    Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):119-126. PubMed ID: 30552056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retreatment efficacy and predictors of ledipasvir plus sofosbuvir to HCV genotype 1 in Japan.
    Akuta N; Sezaki H; Suzuki F; Fujiyama S; Kawamura Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Suzuki Y; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2017 Feb; 89(2):284-290. PubMed ID: 27357737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are there any challenges left in hepatitis C virus therapy of HIV-infected patients?
    Bischoff J; Rockstroh JK
    Int J Antimicrob Agents; 2020 Jul; 56(1):105527. PubMed ID: 30145247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of direct-acting antiviral treatment for chronic hepatitis C in Australia.
    Hajarizadeh B; Grebely J; Matthews GV; Martinello M; Dore GJ
    J Viral Hepat; 2018 Jun; 25(6):640-648. PubMed ID: 29274192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Hepatitis C Virus Infection After Kidney Transplantation With or Without Direct-Acting Antivirals in a Real-Life Setting: A French Multicenter Experience.
    Chevallier E; Büchler M; Caillard S; Bouvier N; Colosio C; Rivalan J; Sayegh J; Bertrand D; Le Meur Y; Thierry A; Garrouste C; Rerolle JP; Rostaing L; Gatault P
    Transplant Proc; 2020 Dec; 52(10):3179-3185. PubMed ID: 32636068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Ledipasvir in Renal Transplant Recipients.
    Eisenberger U; Guberina H; Willuweit K; Bienholz A; Kribben A; Gerken G; Witzke O; Herzer K
    Transplantation; 2017 May; 101(5):980-986. PubMed ID: 27495770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of sexually acquired acute HCV reinfection with ledipasvir/sofosbuvir in a HIV-infected patient.
    Sollima S; Antinori S; Torre A; Binda F; Giacomelli A; Milazzo L
    Int J STD AIDS; 2017 Jul; 28(8):838-840. PubMed ID: 28632109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ledipasvir/Sofosbuvir: a review of its use in chronic hepatitis C.
    Keating GM
    Drugs; 2015 Apr; 75(6):675-85. PubMed ID: 25837989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hepatitis C virus recurrence after transplantation with sofosbuvir/ledipasvir: The role of ribavirin.
    Globke B; Raschzok N; Teegen EM; Pratschke J; Schott E; Eurich D
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27943544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.